Month: February 2026

Hydreight Technologies Issues Fiscal 2026 Revenue Guidance of ≈ $150 Million and Provides Q1 2026 Outlook

Written by Customer Service on February 2, 2026. Posted in Earnings Releases And Operating Results.

VANCOUVER, British Columbia, Feb. 02, 2026 (GLOBE NEWSWIRE) — Hydreight Technologies Inc. (TSXV: NURS) (OTCQB: HYDTF) (FSE: SO6) (“Hydreight” or the “Company”), a provider of compliant digital health infrastructure and on-demand healthcare services across the United States, today issued revenue guidance for the fiscal year ending December 31, 2026, and provided an outlook for the first quarter of fiscal 2026. Fiscal 2026 Revenue Guidance Based on current internal planning assumptions, the Company expects fiscal 2026 revenue of approximately $150 million, representing a conservative baseline outlook reflecting currently contracted demand and visible partner activity.¹ This guidance is intended to represent a baseline or “floor-case” scenario and assumes continued execution across the Company’s existing pharmacy operations and digital...

Inuvo Announces Receipt of $6.2 Million Class Action Settlement

Written by Customer Service on February 2, 2026. Posted in Public Companies.

LITTLE ROCK, Ark., Feb. 02, 2026 (GLOBE NEWSWIRE) — Inuvo, Inc. (NYSE American: INUV), a leading provider of artificial intelligence-driven data and advertising technology solutions, today announced that it has received $6.2 million as a claimant of a class action lawsuit settlement first referenced in its Q3 2025 investor call and recent shareholder update. “This represents an important financial development for Inuvo,” said Rob Buchner, Inuvo Chairman & CEO. “We are pleased to conclude this matter and receive the settlement proceeds, which strengthen our liquidity position and support our strategic priorities going forward.” During the Company’s Q3 2025 investor call, management first disclosed that Inuvo had been a party to a large class action lawsuit that had been settled and that it expected a significant payout in the...

Jeffs’ Brands’ KeepZone AI Will Serve as Hydrogen-Powered Drone Systems’ Prime Contractor to Support Government and Defense Clients

Written by Customer Service on February 2, 2026. Posted in Public Companies.

Tel Aviv, Israel, Feb. 02, 2026 (GLOBE NEWSWIRE) — Jeffs’ Brands Ltd (“Jeffs’ Brands” or the “Company”) (Nasdaq: JFBR, JFBRW), a data-driven e-commerce company operating on the Amazon Marketplace expanding into the global homeland security sector through advanced artificial intelligence (“AI”)-driven solutions, today announced that its wholly-owned subsidiary, KeepZone AI Inc. (“KeepZone”), has secured exclusive rights in Mexico under a commercial agreement (the “Agreement”) with an advanced drone manufacturer(the “Advanced Drone Manufacturer ”) specializing in hydrogen-powered drones. Pursuant to the Agreement KeepZone has been granted exclusive rights in Mexico to market, sell and support the Advanced Drone Manufacturer’s systems, which are designed to support a broad range of operational, logistical and security...

Dimensional Fund Advisors Ltd. : Form 8.3 – PINEWOOD TECHNOLOGIES GROUP – Ordinary Shares

Written by Customer Service on February 2, 2026. Posted in Mergers And Acquisitions.

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BYA PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”)1. KEY INFORMATION (a) Full name of discloser: Dimensional Fund Advisors Ltd. in its capacity as investment advisor and on behalf its affiliates who are also investment advisors (”Dimensional”). Dimensional expressly disclaims beneficial ownership of the shares described in this form 8.3. (b) Owner or controller of interests and short positions disclosed, if different from 1(a):The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. (c) Name of offeror/offeree in relation to whose relevant securities this form relates:Use a separate form for each offeror/offeree Pinewood...

Garrett Motion introduces breakthrough oil-free centrifugal compressor technology for HVAC systems at AHR Expo 2026 in Las Vegas

Written by Customer Service on February 2, 2026. Posted in Public Companies.

Garrett’s compressors enable a fundamental step-change in energy efficiency and use of ultra-low GWP refrigerants. They draw on the company’s leading automotive high-volume technologies. PLYMOUTH, Mich. and ROLLE, Switzerland, Feb. 02, 2026 (GLOBE NEWSWIRE) — Garrett Motion Inc. (Nasdaq: GTX), a global leader in differentiated turbocharging and electrification technologies, unveils its breakthrough oil-free centrifugal compressor technology for HVAC systems at AHR Expo 2026 in Las Vegas (February 2-4) and announces an ambitious roadmap to launch the industry’s first such compressor portfolio covering cooling demands from 7 to 500 Tons (25 to 1,750 kWc). Olivier Rabiller, CEO & President of Garrett Motion, said: “Garrett is leveraging technologies proven in demanding automotive applications to offer differentiated solutions...

Madrigal Pharmaceuticals to Release Fourth-Quarter and Full-Year 2025 Financial Results and Host Webcast on February 19, 2026

Written by Customer Service on February 2, 2026. Posted in Public Companies.

CONSHOHOCKEN, Pa., Feb. 02, 2026 (GLOBE NEWSWIRE) — Madrigal Pharmaceuticals, Inc. (Nasdaq: MDGL) announced today that it will release its fourth-quarter and full-year 2025 financial results on Thursday, Feb. 19, 2026, prior to the open of the U.S. financial markets. Following the announcement, Madrigal’s management will host a live webcast at 8 a.m. Eastern Time to review the Company’s financial and operating results. The live webcast may be accessed at the Investor Relations section of the Madrigal Pharmaceuticals website. To ensure a timely connection, it is recommended that participants register at least 15 minutes prior to the scheduled webcast. The webcast will be available approximately two hours after the live webcast. About Madrigal PharmaceuticalsMadrigal Pharmaceuticals, Inc. (Nasdaq: MDGL) is a biopharmaceutical company...

In Spaceflight Conditions: N2OFF‘s MitoCareX Bio Highlights Co-Founder’s Innovative Research on Mitochondrial Carriers in Microgravity and Cosmic radiation Conditions

Written by Customer Service on February 2, 2026. Posted in Public Companies.

Neve Yarak, Israel, Feb. 02, 2026 (GLOBE NEWSWIRE) — N2OFF, Inc. (NASDAQ: NITO) (“N2OFF” and the “Company”), a drug discovery company that is also investing in solar energy assets based on the RTB (Ready to Build) business model, today highlighted a newly published peer-reviewed study co-authored by Prof. Ciro Leonardo Pierri, co-founder of MitoCareX Bio Ltd. (“MitoCareX Bio”), a specialty biotechnology company developing small‑molecule drugs that target human mitochondrial carriers, its wholly- owned subsidiary. The article, appearing in the Journal of Translational Medicine, investigates SLC25A mitochondrial carriers as potential biomarkers and therapeutic targets for dysfunctions induced by spaceflight conditions, including microgravity and cosmic radiation. The study, titled “SLC25A mitochondrial carriers as biomarkers and...

60 Degrees Pharmaceuticals Expands Access to ARAKODA® with GoodRx Partnership

Written by Customer Service on February 2, 2026. Posted in Public Companies.

GoodRx to offer prescription savings of up to 30% for ARAKODA® (tafenoquine) Collaboration designed to lower patient out-of-pocket costs and expand the reach of Company’s marketing strategy Partnership will improve the affordability of ARAKODA at over 70,000 pharmacies nationwide for people planning travel to malaria-endemic regionsWASHINGTON, Feb. 02, 2026 (GLOBE NEWSWIRE) — 60 Degrees Pharmaceuticals, Inc. (NASDAQ: SXTP; SXTPW) (“60 Degrees Pharma” or the “Company”), a pharmaceutical company focused on developing new medicines for vector-borne disease, today announced a partnership with GoodRx (Nasdaq: GDRX), the leading platform for prescription savings in the U.S., to offer eligible consumers savings of up to 30% on ARAKODA® (tafenoquine). ARAKODA is the only FDA-approved, broad spectrum, once-weekly prescription malaria...

Carlyle to Host 2026 Shareholder Update

Written by Customer Service on February 2, 2026. Posted in Public Companies.

WASHINGTON and NEW YORK, Feb. 02, 2026 (GLOBE NEWSWIRE) — Global investment firm Carlyle (NASDAQ: CG) announced today that it will host a Shareholder Update on Thursday, February 26, 2026. The Shareholder Update will include a series of presentations by the company’s senior leadership team and will review Carlyle’s growth outlook and financial objectives. Presentations will begin at 8:30 a.m. EST, followed by a Q&A session. Presentation materials and a live webcast will be posted on the day of the event and can be accessed on the Events & Presentations section of ir.carlyle.com. For those unable to join the live webcast, a replay will be available on the website following the event. Any questions regarding the 2026 Shareholder Update may be addressed to Carlyle’s Investor Relations team at publicinvestor@carlyle.com. About...

Columbia Financial, Inc. Announces Financial Results for the Fourth Quarter and Year Ended December 31, 2025

Written by Customer Service on February 2, 2026. Posted in Earnings Releases And Operating Results.

FAIR LAWN, N.J., Feb. 02, 2026 (GLOBE NEWSWIRE) — Columbia Financial, Inc. (the “Company”) (NASDAQ: CLBK), the mid-tier holding company for Columbia Bank (“Columbia”), reported net income of $15.7 million, or $0.15 per basic and diluted share, for the quarter ended December 31, 2025, as compared to a net loss of $21.2 million, or $0.21 per basic and diluted share, for the quarter ended December 31, 2024. Earnings for the quarter ended December 31, 2025 reflected higher net interest income due to both an increase in interest income and a decrease in interest expense, a decrease in provision for credit losses and higher non-interest income, partially offset by higher income tax expense. During the fourth quarter of 2024, as previously disclosed, the Company restructured its balance sheet by selling debt securities available...

Month: February 2026

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals